Home Newsfeeds Merrimack Pharmaceuticals Q3 EPS $(0.03) Up From $(0.04) YoY

Merrimack Pharmaceuticals Q3 EPS $(0.03) Up From $(0.04) YoY

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $(0.03) per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

November 3, 2022

1 minute read

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $(0.03) per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year.

Barnes & Noble Stock Pops After The Bell: What’s Going On?

By Adam Eckert

June 5, 5:22 PM

Barnes & Noble announced shareholders voted to approve its previously announced equity and refinancing transactions with Immersion Corp and existing shareholders.

BNED

Cybertruck Without Door Handles Baffles Early Buyers: Tesla CEO Elon Musk Steps In To Solve Confusion

By Benzinga Neuro

December 4, 10:42 PM

The much-anticipated Cybertruck from Tesla Inc. (NASDAQ:TSLA) has hit a snag with its owners due to its unconventional door design.…

TSLA

Digital Ally Announces Deferred Revenue Surpasses $10M Mark; Subscription Payment Plan Continues To See Strong Demand For Its FirstVu Pro Body-Worn Cameras And EVO-HD In-Car Video Solution

By Benzinga Newsdesk

December 14, 9:46 AM

The Company's subscription payment plan continues to see strong demand for its FirstVu Pro body-worn cameras and EVO-HD in-car video solution.LENEXA, KS, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ:DGLY)

DGLY